Does Cutting Weekly Exercise Abolish Nocturnal Non-Capture in Aveir VR?

Primary Research Question

In elderly patients with an Aveir VR leadless pacemaker, does reducing weekly endurance exercise volume from approximately 700 minutes to 350 minutes eliminate nocturnal non-capture by lowering nighttime capture thresholds via autonomic and myocardial effects?

Hypotheses

Primary Hypothesis

Reducing total weekly exercise time from ~700 to ~350 minutes decreases nocturnal parasympathetic predominance and exercise-induced threshold elevation, bringing the required pacing output back below the programmed amplitude of the Aveir VR and thereby abolishing nocturnal non-capture.

Secondary Hypotheses

• Autonomic: Lower training load reduces nighttime vagal surges (higher nocturnal intrinsic heart rate, fewer pauses), shrinking capture threshold variability.
• Myocardial: Less cumulative training stress reduces transient myocardial edema/micro-ischemia and electrolyte shifts, stabilizing the myocardial-electrode interface and thresholds.
• Chronotropic settings interplay: With lower vagal tone, intrinsic rates remain closer to device lower rate limits, reducing demand for higher output or rate-response extremes at night.
• Battery/output margin: A lower, more stable threshold restores a safe output margin without reprogramming.

Proposed Study Design (Pragmatic N-of-1 → Pilot Cohort)

• Population: Adults ≥65 years with Aveir VR who report nocturnal non-capture during high weekly exercise volume (≥600–800 min/week).
• Intervention: Stepwise reduction of weekly exercise to ~350 min/week for 4–6 weeks.
• Comparators: Baseline period at ~700 min/week (self-control), optional crossover back to high volume.
• Monitoring: Device electrograms + threshold trends (if available), overnight Holter, HRV metrics (RMSSD, HF power), sleep HR, nocturnal events (non-capture count), troponin (hs-cTn), electrolytes, and symptom diary.
• Outcomes: Primary—change in nocturnal non-capture events/night. Secondary—change in capture threshold (V at ms), overnight HRV, minimal sleep HR, troponin deltas, symptom scores.
• Success Criterion: ≥80% reduction in nocturnal non-capture nights across 2 consecutive weeks at ~350 min/week vs baseline.

Mechanistic Rationale (Testable)

• Autonomic reset: Training load ↓ → vagal dominance at night ↓ → intrinsic HR ↑ → myocardial excitability ↑ → capture threshold ↓.
• Physiologic stress ↓: Reduced cumulative catecholamine and volume/pressure load → less subclinical myocardial strain → more stable thresholds.
• Electrolyte balance: Lower sweat loss and dilutional effects → fewer nocturnal K⁺/Mg²⁺ deviations that can raise thresholds.

Operational Protocol (Clinic-Ready)

1. Baseline (Weeks −2 to 0): Maintain ~700 min/week; collect nocturnal capture data, HRV, troponin (if clinically indicated), electrolytes, sleep HR.
2. Intervention (Weeks 1–4): Reduce to ~350 min/week; keep intensity ≤ moderate (40–60% VO₂max or 50–70% HRR). Avoid late-evening high-intensity blocks.
3. Device check: Program a fixed safety output margin (e.g., ≥2× measured threshold) without changing between phases unless clinically required.
4. Night monitoring: Weekly overnight Holter or device diagnostics; track non-capture events, thoracic impedance (if available), and sleep HR.
5. Analysis: Paired comparison (baseline vs intervention) using within-subject rate ratios for non-capture events; correlate with HRV and threshold.

Planned Analytics

• Primary: Poisson or negative binomial regression on nightly non-capture counts (offset by nights recorded), within-subject.
• Secondary: Mixed models for threshold (V@ms), HRV (log-transformed), minimal sleep HR; Pearson/Spearman correlations between threshold change and HRV change.
• Exploratory: Mediation analysis: does HRV change mediate the exercise→non-capture effect?

Clinical Implications

• If confirmed, clinicians can prescribe a personalized “exercise dose window” that preserves device capture without sacrificing the benefits of training.
• Supports noninvasive management (exercise titration) before reprogramming or hardware interventions.
• Motivates device algorithms that anticipate threshold drift with autonomic markers (e.g., HRV) and auto-adjust output margins nocturnally.